About CiQUS

Welcome to the web site of the Center for Research in Biological Chemistry and Molecular Materials (CiQUS). Here you will find information about the research areas, groups and scientists that comprise this center, and also about its organization, facilities, services and other data of interest. CiQUS is a member of the Singular Research Centers Network, a core structure of  the Campus of International Excellence– Campus Vida project, and it is focused towards the application of transdisciplinary strategies to solve relevant problems in the field of biological chemistry and in the development of novel functional materials.

News

22-09-2025

O CiQUS participará o vindeiro 26 de setembro na G-Night 2025 cunha actividade divulgativa que achegará a ciencia molecular a públicos de todas as idades.

 
21-08-2025

Researchers at CiQUS have created synthetic microdroplets capable of mimicking basic cellular functions while withstanding salt concentrations similar to those found in the human body. Published in JACS, the study represents a step forward in the construction of artificial cell models with potential biomedical applications.

 
23-07-2025

Researchers at CiQUS have developed a strategy to activate an initially inactive molecule through chemical stimuli, enabling it to recognize and bind to a specific DNA structure known as a three-way junction (3WJ).

 

Scientific Highlights

C. Jiménez-López, L. García-Abuín, E. Fernández-Megía
J. Am. Chem. Soc., 2025, 147, 29457-29467
A. Arribas, A. Rey, M. Calvelo, J.L. Mascareñas, F. López
Angew. Chem. Int. Ed., 2025, 64, e202508252
C. Herreros-Lucas, M. Guillén-Soler, L. Vizcaíno-Anaya, G. Murray, M. Aygün, J.M. Vila-Fungueiriño, M.C. Giménez-López
Adv. Sci., 2025, 12, e05104
R. van der Meel, P.A. Wender, O.M. Merkel, I. Lostalé-Seijo, J. Montenegro, A. Miserez, Q. Laurent, H. Sleiman, P. Luciani
Nat. Rev. Mater., 2025, 10, 490-499

Technology offers

New Compounds Targeting the Cancer Stem Cells Metabolism
 
Enzymatic Immobilization and Recycling
 
Non-viral vehicles to deliver nucleic acid therapeutics